4-Methoxy-7-(morpholin-4-yl)-1,3-benzothiazol-2-amine dihydrobromide, 97%, 250mg

(2E)-1-(4-ethylphenyl)-3-(4-fluorophenyl)prop-2-en-1-one, 95.0%, 10g

beta-Methyllevulinic Acid>98.0%(GC)(T)5g

2-(2-(Benzyloxy)ethoxy)-6-bromopyridine, 5g

3-BENZYL-OCTAHYDROPYRROLO[1,2-A]PYRAZINE-1,4-DIONE, 95%, 1g

METHYL 2,4-DIMETHYL-5-NITROBENZOATE, 95.0%, 1g

tert-Butyl 4-(3-cyanobenzoylamino)piperidine-1-carboxylate, 95.0%, 1g

4-(1-Hydroxyethyl)phenol, 95.0%, 10g

Pipette microlitre monocanal Pipetman® G, 20 à 200 µl, P200G, 1 pièce

6-Ethyl-4-hydroxycoumarin, 97.0%, 1g

[4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)phenyl]acetonitrile, 95.0%, 1g

Methyl 3,4,5-trimethoxy-2-nitrobenzoate, 98.0%, 5g

Ethyl 5-benzyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine-7-carboxylate, 97%, 100mg